Zealand Pharma submits NDA for hyperinsulinism drug dasiglucagon
The NDA includes pivotal data from Phase III trials and a long-term extension, with one trial missing its primary endpoint. Credit: Shutterstock / Africa Studio.
The NDA includes pivotal data from Phase III trials and a long-term extension, with one trial missing its primary endpoint. Credit: Shutterstock / Africa Studio.
News Medical spoke to the CEO and founder of the Maddi Foundation to gain a patient perspective on how important research in gene therapy is.
Australia has taken a significant step by allowing the legal use of MDMA—commonly known as ecstasy— and psilocybin—the hallucinogenic compound found in ‘magic mushrooms’—for the
Bluetongue virus, an incurable cattle and sheep-killing disease, is spread by tiny flies once thought to disappear in winter. New research demonstrates that though they
Celltrion had voiced initial worries about the likely unsustainability of the 2023 VPAS rate long before it was set last December. Credit: Pavel Kapysh /
The first placebo-controlled trial of opioids in acute low back and neck pain.
A UCLA-led team has received $925,000 as part of a new grant from the Centers for Disease Control and Prevention (CDC) to conduct four surveillance
Researchers used antibody testing to predict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Gaining access to Brief Admission by self-referral reduced the need for emergency care in adolescents with severe self-harm.
Camena’s technology aims to provide a highly accurate enzyme-based DNA synthesis. Image credit: Andriy Onufriyenko via Getty Images. Camena Bioscience, a synthetic biology company that